313 related articles for article (PubMed ID: 31422761)
1. Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of
Kumar N; Srivastava R; Prakash A; Lynn AM
J Biomol Struct Dyn; 2020 Jul; 38(11):3396-3410. PubMed ID: 31422761
[TBL] [Abstract][Full Text] [Related]
2. Virtual screening and free energy estimation for identifying Mycobacterium tuberculosis flavoenzyme DprE1 inhibitors.
Niranjan Kumar ; Srivastava R; Prakash A; Lynn AM
J Mol Graph Model; 2021 Jan; 102():107770. PubMed ID: 33065513
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NarL of Mycobacterium Tuberculosis: an in silico approach.
Shivakumar KV; Karunakar P; Chatterjee J
Interdiscip Sci; 2014 Dec; 6(4):292-9. PubMed ID: 25240609
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore model-based virtual screening, docking, biological evaluation and molecular dynamics simulations for inhibitors discovery against
Naz S; Farooq U; Khan S; Sarwar R; Mabkhot YN; Saeed M; Alsayari A; Muhsinah AB; Ul-Haq Z
J Biomol Struct Dyn; 2021 Feb; 39(2):610-620. PubMed ID: 31937192
[TBL] [Abstract][Full Text] [Related]
5. In silico docking and molecular dynamics simulation of 3-dehydroquinate synthase (DHQS) from Mycobacterium tuberculosis.
Isa MA; Majumdhar RS; Haider S
J Mol Model; 2018 May; 24(6):132. PubMed ID: 29752576
[TBL] [Abstract][Full Text] [Related]
6. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.
Kaur G; Pandey B; Kumar A; Garewal N; Grover A; Kaur J
J Biomol Struct Dyn; 2019 Mar; 37(5):1254-1269. PubMed ID: 29557724
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening to identify novel potential inhibitors for Glutamine synthetase of
Kumari M; Subbarao N
J Biomol Struct Dyn; 2020 Oct; 38(17):5062-5080. PubMed ID: 31755360
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel multitarget antitubercular inhibitors against mycobacterial peptidoglycan biosynthetic Mur enzymes by structure-based virtual screening.
Kumari M; Subbarao N
J Biomol Struct Dyn; 2022 Nov; 40(18):8185-8196. PubMed ID: 33826470
[TBL] [Abstract][Full Text] [Related]
9.
Joshi T; Joshi T; Sharma P; Pundir H; Chandra S
J Biomol Struct Dyn; 2021 Aug; 39(13):4816-4834. PubMed ID: 32568603
[TBL] [Abstract][Full Text] [Related]
10. In silico and in vitro study of Mycobacterium tuberculosis H37Rv uncharacterized protein (RipD): an insight on tuberculosis therapeutics.
Arega AM; Dhal AK; Nayak S; Mahapatra RK
J Mol Model; 2022 May; 28(6):171. PubMed ID: 35624324
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of
Chouhan M; Tiwari PK; Moustafa M; Chaubey KK; Gupta A; Kumar R; Sahoo AK; Azhar EI; Dwivedi VD; Kumar S
J Biomol Struct Dyn; 2024; 42(2):948-959. PubMed ID: 37139795
[TBL] [Abstract][Full Text] [Related]
12. "Identification of alkaloid compounds as potent inhibitors of Mycobacterium tuberculosis NadD using computational strategies".
Verma AK; Dubey S; Srivastava SK
Comput Biol Med; 2023 May; 158():106863. PubMed ID: 37030267
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
14. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
15. Isatin-based virtual high throughput screening, molecular docking, DFT, QM/MM, MD and MM-PBSA study of novel inhibitors of SARS-CoV-2 main protease.
Varadharajan V; Arumugam GS; Shanmugam S
J Biomol Struct Dyn; 2022 Oct; 40(17):7852-7867. PubMed ID: 33764269
[TBL] [Abstract][Full Text] [Related]
16. Structure-based identification of natural compound inhibitor against
Lata S; Akif M
J Biomol Struct Dyn; 2021 Aug; 39(12):4480-4489. PubMed ID: 32567497
[TBL] [Abstract][Full Text] [Related]
17. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1.
Khan MKA; Ahmad S; Rabbani G; Shahab U; Khan MS
Cell Biochem Funct; 2022 Jul; 40(5):451-472. PubMed ID: 35758564
[TBL] [Abstract][Full Text] [Related]
18. Identification of New
Almeleebia TM; Shahrani MA; Alshahrani MY; Ahmad I; Alkahtani AM; Alam MJ; Kausar MA; Saeed A; Saeed M; Iram S
Molecules; 2021 Apr; 26(8):. PubMed ID: 33923734
[No Abstract] [Full Text] [Related]
19. Homology modeling and molecular dynamic simulation of UDP-N-acetylmuramoyl-l-alanine-d-glutamate ligase (MurD) from Mycobacterium tuberculosis H37Rv using in silico approach.
Isa MA
Comput Biol Chem; 2019 Feb; 78():116-126. PubMed ID: 30504089
[TBL] [Abstract][Full Text] [Related]
20. Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target "mtFabH" of
Kumar N; Srivastava R; Mongre RK; Mishra CB; Kumar A; Khatoon R; Banerjee A; Ashraf-Uz-Zaman M; Singh H; Lynn AM; Lee MS; Prakash A
Front Microbiol; 2022; 13():818714. PubMed ID: 35602011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
